Your browser doesn't support javascript.
loading
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.
Radovich, Milan; Solzak, Jeffrey P; Wang, Chao J; Hancock, Bradley A; Badve, Sunil; Althouse, Sandra K; Bray, Steven M; Storniolo, Anna Maria V; Ballinger, Tarah J; Schneider, Bryan P; Miller, Kathy D.
Affiliation
  • Radovich M; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
  • Solzak JP; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Wang CJ; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Hancock BA; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Badve S; Department of Surgery, Division of Surgical Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Althouse SK; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
  • Bray SM; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Storniolo AMV; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
  • Ballinger TJ; Department of Biostatistics and Data Health Science, Indiana University School of Medicine, Indianapolis, Indiana.
  • Schneider BP; LifeOmic, LLC, Indianapolis, Indiana.
  • Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana.
Clin Cancer Res ; 28(15): 3235-3241, 2022 08 02.
Article in En | MEDLINE | ID: mdl-35551360
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoconjugates / Triple Negative Breast Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoconjugates / Triple Negative Breast Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Type: Article